Vernalis PLC Share News (VER)
VER Share
VER Share
VER Share
VER Share
VER
VER Share
VER Broker
VER Directors
VER Financial
VER
VER Short
VERThu, 16th Aug 2018 13:57
LONDON (Alliance News) - Pharmaceutical firm Vernalis PLC on Thursday said Ian Gilham is leaving his role as a non-executive director.
Chairman Peter Fellner said: "We would like to thank Ian for his contributions to the board over the last three years and the board wishes him well in his future endeavours."
A week ago, Vernalis agreed a takeover with Ligand Holdings UK Ltd, which will see the latter buy Vernalis for GBP32.7 million.
Shares were untraded on Thursday, last quoted at 6.10 pence.
LONDON, Dec 19 (Reuters) - Shares in Vernalis fell sharply on Friday as Swiss drugmaker Novartis stopped development work on a drug licensed from the British biotech company 10 years ago. Vernalis said Novartis had handed back rights to AUY922 after studying it as a treatment for a range of
Read more
TSB Banking: Shore Capital reiterates buy with a target price for 325p. Vernalis: Canaccord Genuity ups target to 66p from 56p and reiterates buy. Aggreko: Panmure Gordon and Investec reiterate hold. Gemfields: Numis initiates coverage with a buy recommendation and 70p target price. Ithaca Energy
Read more